Penumbra Shares Soar Pre-Market — What Is The Boston Scientific Agreement?
Synopsis
Boston Scientific stated that it has agreed to acquire Penumbra in a cash-and-stock transaction that values the latter at an enterprise value of $14.5 billion.
Penumbra Inc. (PEN) shares soared 14% in Thursday’s pre-market trade after Boston Scientific Corp. (BSX) announced an agreement to acquire the global healthcare company.
Boston Scientific stated that it has agreed to acquire Penumbra in a cash-and-stock transaction that values the latter at an enterprise value of $14.5 billion.
Boston Scientific shares were down nearly 3% in Thursday’s pre-market session. Retail sentiment on Stocktwits around Boston Scientific trended in the ‘bullish’ territory, while users felt ‘extremely bullish’ about Penumbra.
Get updates to this developing story directly on Stocktwits.<
For updates and corrections, email newsroom[at]stocktwits[dot]com.<
Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.